| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | DNAH14 DNAH5 DNAH6 DNAH8 DNHD1 DNAH3 DNAH2 DNAH7 DNAH1 DNAH17 DNAH11 | 2.88e-18 | 18 | 204 | 11 | GO:0008569 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | DNAH14 DNAH5 DNAH6 DNAH8 DNHD1 DNAH3 DNAH2 DNAH7 DNAH1 DNAH17 DNAH11 | 1.78e-15 | 28 | 204 | 11 | GO:0051959 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | DNAH14 DNAH5 DNAH6 DNAH8 DNHD1 DNAH3 DNAH2 DNAH7 DNAH1 DNAH17 DNAH11 | 6.54e-14 | 37 | 204 | 11 | GO:0045505 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | MYH11 DNAH14 DNAH5 DNAH6 DNAH8 DNHD1 DNAH3 DNAH2 MYO18A DNAH7 DNAH1 DNAH17 MYO15A DNAH11 | 1.77e-11 | 118 | 204 | 14 | GO:0003774 |
| GeneOntologyMolecularFunction | microtubule motor activity | DNAH14 DNAH5 DNAH6 DNAH8 DNHD1 DNAH3 DNAH2 DNAH7 DNAH1 DNAH17 DNAH11 | 1.23e-10 | 70 | 204 | 11 | GO:0003777 |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 3.10e-09 | 37 | 204 | 8 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 3.89e-09 | 38 | 204 | 8 | GO:0070001 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH11 CHD2 DNAH14 MDN1 DNAH5 DNAH6 DHX29 DNAH8 DNHD1 DNAH3 EP400 DNAH2 MYO18A CHD9 NLRP1 DNAH7 DNAH1 DNAH17 UBA6 MACF1 MYO15A DNAH11 | 3.55e-07 | 614 | 204 | 22 | GO:0140657 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 3.30e-06 | 11 | 204 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 9.77e-06 | 14 | 204 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity | 2.05e-05 | 6 | 204 | 3 | GO:0017083 | |
| GeneOntologyMolecularFunction | sphingosine N-acyltransferase activity | 3.57e-05 | 7 | 204 | 3 | GO:0050291 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 5.52e-05 | 21 | 204 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | alpha-(1->3)-fucosyltransferase activity | 5.67e-05 | 8 | 204 | 3 | GO:0046920 | |
| GeneOntologyMolecularFunction | alpha-glucoside transmembrane transporter activity | 1.04e-04 | 2 | 204 | 2 | GO:0015151 | |
| GeneOntologyMolecularFunction | protein-glycine ligase activity, initiating | 1.04e-04 | 2 | 204 | 2 | GO:0070736 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 1.33e-04 | 26 | 204 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | CHD2 MDN1 DNAH5 DNAH6 DHX29 DNAH8 DNAH3 DNAH2 MYO18A CHD9 NLRP1 DNAH7 MACF1 DNAH11 | 1.86e-04 | 441 | 204 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | glucoside transmembrane transporter activity | 3.10e-04 | 3 | 204 | 2 | GO:0042947 | |
| GeneOntologyMolecularFunction | protein-glycine ligase activity | 3.10e-04 | 3 | 204 | 2 | GO:0070735 | |
| GeneOntologyMolecularFunction | fucosyltransferase activity | 3.52e-04 | 14 | 204 | 3 | GO:0008417 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 5.33e-04 | 16 | 204 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 5.36e-04 | 37 | 204 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 5.95e-04 | 38 | 204 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 6.43e-04 | 17 | 204 | 3 | GO:0099508 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 9.02e-04 | 19 | 204 | 3 | GO:0004890 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 9.73e-04 | 152 | 204 | 7 | GO:0016779 | |
| GeneOntologyMolecularFunction | activin receptor activity, type I | 1.02e-03 | 5 | 204 | 2 | GO:0016361 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity, type I | 1.02e-03 | 5 | 204 | 2 | GO:0005025 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 1.02e-03 | 5 | 204 | 2 | GO:0030156 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 1.11e-03 | 201 | 204 | 8 | GO:0061135 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.22e-03 | 21 | 204 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.23e-03 | 46 | 204 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.29e-03 | 79 | 204 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 1.35e-03 | 257 | 204 | 9 | GO:0061134 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 1.40e-03 | 22 | 204 | 3 | GO:0016917 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.54e-03 | 262 | 204 | 9 | GO:0140097 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-19 ERVK-24 USP48 RHBDF1 NLRP1 USP6 ERVK-8 | 1.62e-03 | 430 | 204 | 12 | GO:0004175 |
| GeneOntologyMolecularFunction | sodium channel activity | 1.95e-03 | 52 | 204 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | D-glucose:sodium symporter activity | 2.11e-03 | 7 | 204 | 2 | GO:0005412 | |
| GeneOntologyMolecularFunction | tumor necrosis factor binding | 2.11e-03 | 7 | 204 | 2 | GO:0043120 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 2.11e-03 | 7 | 204 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 2.30e-03 | 26 | 204 | 3 | GO:0050431 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 2.56e-03 | 180 | 204 | 7 | GO:0004866 | |
| GeneOntologyMolecularFunction | MAP kinase kinase kinase activity | 2.57e-03 | 27 | 204 | 3 | GO:0004709 | |
| GeneOntologyMolecularFunction | endonuclease activity | 2.77e-03 | 136 | 204 | 6 | GO:0004519 | |
| GeneOntologyMolecularFunction | BMP receptor activity | 2.79e-03 | 8 | 204 | 2 | GO:0098821 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 3.16e-03 | 187 | 204 | 7 | GO:0030414 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | ERVK-6 ILK ERVK-7 ERVK-10 ACVR1 ACVRL1 MAP3K12 MAP3K7 POLR2B AATK RPAP1 GUCY2D MARK4 ERVK-8 UBA6 ROCK1 ROS1 MAP3K13 G6PC1 | 3.57e-03 | 938 | 204 | 19 | GO:0016772 |
| GeneOntologyMolecularFunction | activin receptor activity | 3.57e-03 | 9 | 204 | 2 | GO:0017002 | |
| GeneOntologyBiologicalProcess | cilium movement involved in cell motility | TTLL3 DNAH14 DNAH5 TBC1D21 DNAH6 DNAH8 DNHD1 DNAH3 DNAH2 CFAP43 TTLL8 DNAH7 DNAH1 DNAH17 DNAH11 | 2.72e-09 | 210 | 203 | 15 | GO:0060294 |
| GeneOntologyBiologicalProcess | cilium-dependent cell motility | TTLL3 DNAH14 DNAH5 TBC1D21 DNAH6 DNAH8 DNHD1 DNAH3 DNAH2 CFAP43 TTLL8 DNAH7 DNAH1 DNAH17 DNAH11 | 3.76e-09 | 215 | 203 | 15 | GO:0060285 |
| GeneOntologyBiologicalProcess | cilium or flagellum-dependent cell motility | TTLL3 DNAH14 DNAH5 TBC1D21 DNAH6 DNAH8 DNHD1 DNAH3 DNAH2 CFAP43 TTLL8 DNAH7 DNAH1 DNAH17 DNAH11 | 3.76e-09 | 215 | 203 | 15 | GO:0001539 |
| GeneOntologyBiologicalProcess | cilium movement | TTLL3 DNAH14 DNAH5 TBC1D21 DNAH6 DNAH8 DNHD1 DNAH3 DNAH2 CFAP43 TTLL8 DNAH7 DNAH1 NPHP3 DNAH17 DNAH11 | 7.18e-09 | 261 | 203 | 16 | GO:0003341 |
| GeneOntologyBiologicalProcess | axoneme assembly | 1.32e-06 | 109 | 203 | 9 | GO:0035082 | |
| GeneOntologyBiologicalProcess | cilium assembly | GBF1 TTLL3 TBC1D24 DNAH5 TBC1D21 DNAH8 DNHD1 DNAH2 CFAP43 ARHGAP35 TTLL8 DNAH7 TBC1D17 DNAH1 NPHP3 DNAH17 MARK4 | 2.06e-06 | 444 | 203 | 17 | GO:0060271 |
| GeneOntologyBiologicalProcess | axonemal dynein complex assembly | 2.85e-06 | 41 | 203 | 6 | GO:0070286 | |
| GeneOntologyBiologicalProcess | cilium organization | GBF1 TTLL3 TBC1D24 DNAH5 TBC1D21 DNAH8 DNHD1 DNAH2 CFAP43 ARHGAP35 TTLL8 DNAH7 TBC1D17 DNAH1 NPHP3 DNAH17 MARK4 | 5.21e-06 | 476 | 203 | 17 | GO:0044782 |
| GeneOntologyBiologicalProcess | DNA integration | 6.08e-06 | 13 | 203 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | microtubule bundle formation | 1.39e-05 | 145 | 203 | 9 | GO:0001578 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 2.08e-05 | 85 | 203 | 7 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 2.08e-05 | 85 | 203 | 7 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 2.81e-05 | 89 | 203 | 7 | GO:0006949 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | TTLL3 DNAH14 DNAH5 TBC1D21 DNAH6 DNAH8 DNHD1 DNAH3 DNAH2 CFAP43 TTLL8 DNAH7 DNAH1 NPHP3 DNAH17 DNAH11 | 3.20e-05 | 493 | 203 | 16 | GO:0007018 |
| GeneOntologyBiologicalProcess | positive regulation of apoptotic cell clearance | 5.07e-05 | 8 | 203 | 3 | GO:2000427 | |
| GeneOntologyBiologicalProcess | L-fucose catabolic process | 7.55e-05 | 9 | 203 | 3 | GO:0042355 | |
| GeneOntologyBiologicalProcess | fucose catabolic process | 7.55e-05 | 9 | 203 | 3 | GO:0019317 | |
| GeneOntologyBiologicalProcess | alpha-glucoside transport | 9.64e-05 | 2 | 203 | 2 | GO:0000017 | |
| GeneOntologyBiologicalProcess | apoptotic cell clearance | 1.07e-04 | 48 | 203 | 5 | GO:0043277 | |
| GeneOntologyBiologicalProcess | L-fucose metabolic process | 1.07e-04 | 10 | 203 | 3 | GO:0042354 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic cell clearance | 1.07e-04 | 10 | 203 | 3 | GO:2000425 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | GBF1 TTLL3 TBC1D24 DNAH5 TBC1D21 DNAH8 DNHD1 DNAH2 CFAP43 ARHGAP35 TTLL8 DNAH7 TBC1D17 DNAH1 NPHP3 DNAH17 MARK4 ROCK1 | 1.18e-04 | 670 | 203 | 18 | GO:0120031 |
| GeneOntologyBiologicalProcess | cell projection assembly | GBF1 TTLL3 TBC1D24 DNAH5 TBC1D21 DNAH8 DNHD1 DNAH2 CFAP43 ARHGAP35 TTLL8 DNAH7 TBC1D17 DNAH1 NPHP3 DNAH17 MARK4 ROCK1 | 1.56e-04 | 685 | 203 | 18 | GO:0030031 |
| GeneOntologyBiologicalProcess | viral process | ERVK-6 SLC6A19 ERVK-7 ERVK-21 ERVK-9 ERVK-10 STAT1 EIF3L ERVK-19 ERVK-24 CANX ERVK-8 ERVK-5 HYAL2 | 2.14e-04 | 464 | 203 | 14 | GO:0016032 |
| GeneOntologyBiologicalProcess | epithelial cilium movement involved in extracellular fluid movement | 2.86e-04 | 59 | 203 | 5 | GO:0003351 | |
| GeneOntologyBiologicalProcess | glucoside transport | 2.87e-04 | 3 | 203 | 2 | GO:0042946 | |
| GeneOntologyBiologicalProcess | protein polyglycylation | 2.87e-04 | 3 | 203 | 2 | GO:0018094 | |
| GeneOntologyBiologicalProcess | extracellular transport | 3.61e-04 | 62 | 203 | 5 | GO:0006858 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 4.19e-04 | 36 | 203 | 4 | GO:0086010 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.15e-12 | 25 | 203 | 9 | GO:0005858 | |
| GeneOntologyCellularComponent | dynein complex | DNAH14 DNAH5 DNAH6 DNAH8 DNHD1 DNAH3 DNAH2 DNAH7 DNAH1 DNAH17 DNAH11 | 3.67e-12 | 54 | 203 | 11 | GO:0030286 |
| GeneOntologyCellularComponent | inner dynein arm | 1.58e-10 | 10 | 203 | 6 | GO:0036156 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | TTLL3 DNAH14 DNAH5 TBC1D21 DNAH6 DNAH8 DNHD1 DNAH3 DNAH2 CFAP43 TTLL8 DNAH7 DNAH1 CCDC34 DNAH17 DNAH11 | 1.58e-09 | 238 | 203 | 16 | GO:0097729 |
| GeneOntologyCellularComponent | axoneme | TTLL3 DNAH5 DNAH6 DNAH8 DNHD1 DNAH3 DNAH2 AMBRA1 CFAP43 TTLL8 DNAH7 DNAH1 DNAH17 DNAH11 | 1.59e-08 | 207 | 203 | 14 | GO:0005930 |
| GeneOntologyCellularComponent | ciliary plasm | TTLL3 DNAH5 DNAH6 DNAH8 DNHD1 DNAH3 DNAH2 AMBRA1 CFAP43 TTLL8 DNAH7 DNAH1 DNAH17 DNAH11 | 1.69e-08 | 208 | 203 | 14 | GO:0097014 |
| GeneOntologyCellularComponent | motile cilium | TTLL3 DNAH14 DNAH5 TBC1D21 DNAH6 DNAH8 DNHD1 DNAH3 DNAH2 CFAP43 TTLL8 DNAH7 DNAH1 CCDC34 DNAH17 DNAH11 | 4.18e-07 | 355 | 203 | 16 | GO:0031514 |
| GeneOntologyCellularComponent | microtubule associated complex | DNAH14 DNAH5 DNAH6 DNAH8 DNHD1 DNAH3 DNAH2 DNAH7 DNAH1 DNAH17 DNAH11 | 5.17e-07 | 161 | 203 | 11 | GO:0005875 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | TTLL3 DNAH5 DNAH6 DNAH8 DNHD1 DNAH3 CANX DNAH2 AMBRA1 CFAP43 TTLL8 DNAH7 DNAH1 DNAH17 DNAH11 | 5.27e-07 | 317 | 203 | 15 | GO:0032838 |
| GeneOntologyCellularComponent | cytoplasmic region | TTLL3 DNAH5 DNAH6 DNAH8 DNHD1 DNAH3 CANX DNAH2 AMBRA1 CFAP43 TTLL8 DNAH7 DNAH1 DNAH17 DNAH11 | 2.57e-06 | 360 | 203 | 15 | GO:0099568 |
| GeneOntologyCellularComponent | cilium | TTLL3 INHA DNAH14 FFAR4 USP48 DNAH5 TBC1D21 DNAH6 DNAH8 DNHD1 DNAH3 DNAH2 AMBRA1 CFAP43 ARHGAP35 TTLL8 DNAH7 DNAH1 NPHP3 CCDC34 GUCY2D DNAH17 MARK4 DNAH11 | 7.23e-06 | 898 | 203 | 24 | GO:0005929 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.86e-05 | 17 | 203 | 4 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.70e-04 | 29 | 203 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | outer dynein arm | 1.86e-04 | 12 | 203 | 3 | GO:0036157 | |
| GeneOntologyCellularComponent | microtubule | TTLL3 EML6 DYSF DNAH14 DNAH5 DNAH6 DNAH8 DNAH3 DNAH2 TTLL8 DNAH7 DNAH1 DNAH17 MACF1 DNAH11 | 2.35e-04 | 533 | 203 | 15 | GO:0005874 |
| GeneOntologyCellularComponent | sperm flagellum | 2.54e-04 | 214 | 203 | 9 | GO:0036126 | |
| GeneOntologyCellularComponent | cell projection membrane | GABRG1 GABRG2 CYBRD1 SLC6A19 FFAR4 SLC12A5 PTPRH PLD2 SLC5A1 SLC5A2 GUCY2D KIRREL1 MACF1 | 3.18e-04 | 431 | 203 | 13 | GO:0031253 |
| GeneOntologyCellularComponent | BMP receptor complex | 5.56e-04 | 4 | 203 | 2 | GO:0070724 | |
| GeneOntologyCellularComponent | brush border | 7.25e-04 | 152 | 203 | 7 | GO:0005903 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 7.80e-04 | 19 | 203 | 3 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 1.05e-03 | 21 | 203 | 3 | GO:1902710 | |
| GeneOntologyCellularComponent | brush border membrane | 1.29e-03 | 83 | 203 | 5 | GO:0031526 | |
| GeneOntologyCellularComponent | 9+0 motile cilium | 1.37e-03 | 6 | 203 | 2 | GO:0097728 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 1.56e-03 | 223 | 203 | 8 | GO:0098862 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 1.57e-03 | 332 | 203 | 10 | GO:0005788 | |
| GeneOntologyCellularComponent | myosin filament | 1.77e-03 | 25 | 203 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | symbiont cell surface | 2.53e-03 | 8 | 203 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH11 ILK TTLL3 EML6 DYSF DNAH14 SCN1A ACTL9 DNAH5 DNAH6 DNAH8 DNAH3 MTMR12 DNAH2 MYO18A TTLL8 DNAH7 DNAH1 DNAH17 MACF1 DNAH11 MYBPC2 | 2.56e-03 | 1179 | 203 | 22 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH11 ILK TTLL3 EML6 DYSF DNAH14 SCN1A ACTL9 DNAH5 DNAH6 DNAH8 DNAH3 MTMR12 DNAH2 MYO18A TTLL8 DNAH7 DNAH1 DNAH17 MACF1 DNAH11 MYBPC2 | 2.77e-03 | 1187 | 203 | 22 | GO:0099081 |
| GeneOntologyCellularComponent | other organism part | 3.23e-03 | 9 | 203 | 2 | GO:0044217 | |
| HumanPheno | Short sperm flagella | 7.94e-09 | 33 | 69 | 8 | HP:0032559 | |
| HumanPheno | Absent sperm flagella | 5.80e-08 | 28 | 69 | 7 | HP:0032558 | |
| HumanPheno | Abnormal sperm tail morphology | 7.45e-08 | 43 | 69 | 8 | HP:0012868 | |
| HumanPheno | Coiled sperm flagella | 1.58e-07 | 32 | 69 | 7 | HP:0032560 | |
| HumanPheno | Abnormal sperm morphology | 1.80e-07 | 66 | 69 | 9 | HP:0012864 | |
| HumanPheno | Abnormal germ cell morphology | 2.06e-07 | 67 | 69 | 9 | HP:0012862 | |
| HumanPheno | Abnormal male germ cell morphology | 2.06e-07 | 67 | 69 | 9 | HP:0012863 | |
| HumanPheno | Reduced sperm motility | 2.67e-07 | 69 | 69 | 9 | HP:0012207 | |
| HumanPheno | Abnormal sperm motility | GANAB DNAH5 DNAH8 DNHD1 DNAH2 CFAP43 DNAH7 DNAH1 CCDC34 DNAH17 DNAH11 | 2.91e-07 | 115 | 69 | 11 | HP:0012206 |
| HumanPheno | Abnormal sperm physiology | GANAB DNAH5 DNAH8 DNHD1 DNAH2 CFAP43 DNAH7 DNAH1 CCDC34 DNAH17 DNAH11 | 2.91e-07 | 115 | 69 | 11 | HP:0034809 |
| HumanPheno | Visually-induced seizure | 2.94e-06 | 18 | 69 | 5 | HP:0020216 | |
| HumanPheno | Limitation of knee mobility | 5.90e-06 | 35 | 69 | 6 | HP:0010501 | |
| HumanPheno | Reflex seizure | 8.67e-06 | 22 | 69 | 5 | HP:0020207 | |
| HumanPheno | Focal hemiclonic seizure | 1.70e-05 | 25 | 69 | 5 | HP:0006813 | |
| HumanPheno | Generalized cerebral atrophy/hypoplasia | 2.01e-05 | 13 | 69 | 4 | HP:0007058 | |
| HumanPheno | EEG with irregular generalized spike and wave complexes | 2.01e-05 | 13 | 69 | 4 | HP:0001326 | |
| HumanPheno | Limited knee extension | 2.52e-05 | 27 | 69 | 5 | HP:0003066 | |
| HumanPheno | Status epilepticus without prominent motor symptoms | 2.52e-05 | 27 | 69 | 5 | HP:0031475 | |
| HumanPheno | Multifocal epileptiform discharges | 2.54e-05 | 66 | 69 | 7 | HP:0010841 | |
| HumanPheno | Aortopulmonary collateral arteries | 3.76e-05 | 15 | 69 | 4 | HP:0031834 | |
| HumanPheno | Irregularly shaped sperm tail | 3.76e-05 | 15 | 69 | 4 | HP:0033393 | |
| HumanPheno | Photosensitive tonic-clonic seizure | 3.76e-05 | 15 | 69 | 4 | HP:0007207 | |
| HumanPheno | Dysgenesis of the hippocampus | 4.96e-05 | 16 | 69 | 4 | HP:0025101 | |
| HumanPheno | EEG with focal spike waves | 4.96e-05 | 16 | 69 | 4 | HP:0011197 | |
| HumanPheno | Bilateral tonic-clonic seizure with focal onset | 6.18e-05 | 52 | 69 | 6 | HP:0007334 | |
| HumanPheno | Bilateral tonic-clonic seizure with generalized onset | 6.18e-05 | 52 | 69 | 6 | HP:0025190 | |
| HumanPheno | Atypical absence status epilepticus | 6.43e-05 | 17 | 69 | 4 | HP:0011151 | |
| HumanPheno | Focal emotional seizure with laughing | 6.43e-05 | 17 | 69 | 4 | HP:0010821 | |
| HumanPheno | Generalized non-convulsive status epilepticus without coma | 8.18e-05 | 18 | 69 | 4 | HP:0032860 | |
| HumanPheno | Focal emotional seizure | 8.18e-05 | 18 | 69 | 4 | HP:0025613 | |
| HumanPheno | Male infertility | ACTL9 DNAH5 DNAH8 DNHD1 DNAH2 CFAP43 DNAH7 DNAH1 CCDC34 DNAH17 DNAH11 | 9.56e-05 | 209 | 69 | 11 | HP:0003251 |
| HumanPheno | Non-convulsive status epilepticus without coma | 1.27e-04 | 20 | 69 | 4 | HP:0032671 | |
| HumanPheno | Photosensitive myoclonic seizure | 1.27e-04 | 8 | 69 | 3 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 1.27e-04 | 8 | 69 | 3 | HP:0200048 | |
| HumanPheno | Abnormal knee physiology | 1.52e-04 | 87 | 69 | 7 | HP:0034670 | |
| HumanPheno | Talipes valgus | 1.55e-04 | 21 | 69 | 4 | HP:0004684 | |
| HumanPheno | Tibial torsion | 2.25e-04 | 23 | 69 | 4 | HP:0100694 | |
| HumanPheno | Focal clonic seizure | 2.27e-04 | 42 | 69 | 5 | HP:0002266 | |
| HumanPheno | Focal impaired awareness seizure | 2.65e-04 | 126 | 69 | 8 | HP:0002384 | |
| HumanPheno | Decreased fertility in males | ACTL9 DNAH5 DNAH8 DNHD1 DNAH2 CFAP43 DNAH7 DNAH1 CCDC34 DNAH17 DNAH11 | 2.81e-04 | 236 | 69 | 11 | HP:0012041 |
| HumanPheno | Atypical absence seizure | 3.51e-04 | 46 | 69 | 5 | HP:0007270 | |
| HumanPheno | Limited neck range of motion | 3.63e-04 | 11 | 69 | 3 | HP:0000466 | |
| HumanPheno | Epileptic spasm | RALGAPA1 GABRG2 CHD2 TBC1D24 SLC12A5 SCN1A SCN2A PPFIBP1 ARFGEF1 MACF1 | 4.11e-04 | 207 | 69 | 10 | HP:0011097 |
| HumanPheno | Simple febrile seizure | 4.28e-04 | 27 | 69 | 4 | HP:0011171 | |
| HumanPheno | Abnormal hippocampus morphology | 4.29e-04 | 48 | 69 | 5 | HP:0025100 | |
| HumanPheno | Abnormal morphology of the limbic system | 4.73e-04 | 49 | 69 | 5 | HP:0007343 | |
| HumanPheno | Epilepsia partialis continua | 4.80e-04 | 12 | 69 | 3 | HP:0012847 | |
| HumanPheno | Myoclonic seizure | GABRD GABRG2 CHD2 TBC1D24 SLC12A5 SCN1A SCN2A HACE1 PPFIBP1 ARFGEF1 MACF1 | 6.87e-04 | 262 | 69 | 11 | HP:0032794 |
| HumanPheno | Generalized myoclonic seizure | 7.83e-04 | 148 | 69 | 8 | HP:0002123 | |
| Domain | Dynein_HC_stalk | DNAH14 DNAH5 DNAH6 DNAH8 DNHD1 DNAH3 DNAH2 DNAH7 DNAH1 DNAH11 | 1.12e-17 | 14 | 194 | 10 | IPR024743 |
| Domain | MT | DNAH14 DNAH5 DNAH6 DNAH8 DNHD1 DNAH3 DNAH2 DNAH7 DNAH1 DNAH11 | 1.12e-17 | 14 | 194 | 10 | PF12777 |
| Domain | DHC_fam | DNAH14 DNAH5 DNAH6 DNAH8 DNHD1 DNAH3 DNAH2 DNAH7 DNAH1 DNAH11 | 3.32e-17 | 15 | 194 | 10 | IPR026983 |
| Domain | Dynein_heavy | DNAH14 DNAH5 DNAH6 DNAH8 DNHD1 DNAH3 DNAH2 DNAH7 DNAH1 DNAH11 | 3.32e-17 | 15 | 194 | 10 | PF03028 |
| Domain | Dynein_heavy_dom | DNAH14 DNAH5 DNAH6 DNAH8 DNHD1 DNAH3 DNAH2 DNAH7 DNAH1 DNAH11 | 3.32e-17 | 15 | 194 | 10 | IPR004273 |
| Domain | Dynein_heavy_chain_D4_dom | 2.24e-15 | 14 | 194 | 9 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 2.24e-15 | 14 | 194 | 9 | IPR013602 | |
| Domain | DHC_N2 | 2.24e-15 | 14 | 194 | 9 | PF08393 | |
| Domain | AAA_8 | 2.24e-15 | 14 | 194 | 9 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 3.34e-13 | 14 | 194 | 8 | IPR011704 | |
| Domain | AAA_5 | 3.34e-13 | 14 | 194 | 8 | PF07728 | |
| Domain | A2M | 2.77e-08 | 10 | 194 | 5 | PF00207 | |
| Domain | A2M_N_2 | 2.77e-08 | 10 | 194 | 5 | IPR011625 | |
| Domain | A2M_comp | 2.77e-08 | 10 | 194 | 5 | IPR011626 | |
| Domain | A2M_recep | 2.77e-08 | 10 | 194 | 5 | PF07677 | |
| Domain | A2M_comp | 2.77e-08 | 10 | 194 | 5 | PF07678 | |
| Domain | A2M_N | 2.77e-08 | 10 | 194 | 5 | PF01835 | |
| Domain | A2M_N | 2.77e-08 | 10 | 194 | 5 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 2.77e-08 | 10 | 194 | 5 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 2.77e-08 | 10 | 194 | 5 | PS00477 | |
| Domain | A2M_N_2 | 2.77e-08 | 10 | 194 | 5 | PF07703 | |
| Domain | Macroglobln_a2 | 2.77e-08 | 10 | 194 | 5 | IPR001599 | |
| Domain | DHC_N1 | 7.65e-07 | 8 | 194 | 4 | PF08385 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 7.65e-07 | 8 | 194 | 4 | IPR019565 | |
| Domain | Thiol-ester_cl | 7.65e-07 | 8 | 194 | 4 | PF10569 | |
| Domain | MacrogloblnA2_CS | 7.65e-07 | 8 | 194 | 4 | IPR019742 | |
| Domain | Dynein_heavy_dom-1 | 7.65e-07 | 8 | 194 | 4 | IPR013594 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 8.82e-07 | 18 | 194 | 5 | IPR008930 | |
| Domain | - | MFHAS1 CHD2 DNAH14 MDN1 DNAH5 DNAH6 DHX29 DNAH8 DNHD1 DNAH3 EP400 APAF1 DNAH2 MYO18A CHD9 NLRP1 ARHGAP35 DNAH7 DNAH1 NPHP3 MYO15A DNAH11 | 1.07e-05 | 746 | 194 | 22 | 3.40.50.300 |
| Domain | Anaphylatoxin_comp_syst | 1.09e-05 | 5 | 194 | 3 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 1.09e-05 | 5 | 194 | 3 | IPR001840 | |
| Domain | Lag1/Lac1 | 2.16e-05 | 6 | 194 | 3 | IPR016439 | |
| Domain | P-loop_NTPase | MYH11 MFHAS1 CHD2 DNAH14 MDN1 DNAH5 DNAH6 DHX29 DNAH8 DNHD1 DNAH3 EP400 APAF1 DNAH2 MYO18A CHD9 NLRP1 ARHGAP35 DNAH7 DNAH1 NPHP3 MYO15A DNAH11 | 2.52e-05 | 848 | 194 | 23 | IPR027417 |
| Domain | ANATO | 3.75e-05 | 7 | 194 | 3 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 3.75e-05 | 7 | 194 | 3 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 3.75e-05 | 7 | 194 | 3 | PS01177 | |
| Domain | ANATO | 3.75e-05 | 7 | 194 | 3 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 3.75e-05 | 7 | 194 | 3 | IPR000020 | |
| Domain | IQ_motif_EF-hand-BS | 4.22e-05 | 90 | 194 | 7 | IPR000048 | |
| Domain | IQ | 5.22e-05 | 93 | 194 | 7 | PS50096 | |
| Domain | Glyco_transf_10 | 5.95e-05 | 8 | 194 | 3 | PF00852 | |
| Domain | Glyco_tran_10_N | 5.95e-05 | 8 | 194 | 3 | PF17039 | |
| Domain | Glyco_tran_10_N | 5.95e-05 | 8 | 194 | 3 | IPR031481 | |
| Domain | Glyco_trans_10 | 5.95e-05 | 8 | 194 | 3 | IPR001503 | |
| Domain | A2M_N_2 | 5.95e-05 | 8 | 194 | 3 | SM01359 | |
| Domain | - | 5.95e-05 | 8 | 194 | 3 | 2.60.40.690 | |
| Domain | A2M_recep | 5.95e-05 | 8 | 194 | 3 | SM01361 | |
| Domain | A2M | 5.95e-05 | 8 | 194 | 3 | SM01360 | |
| Domain | Pkinase_Tyr | 6.12e-05 | 129 | 194 | 8 | PF07714 | |
| Domain | IQ | 9.50e-05 | 71 | 194 | 6 | PF00612 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 9.84e-05 | 138 | 194 | 8 | IPR001245 | |
| Domain | MAP3K12_MAP3K13 | 1.07e-04 | 2 | 194 | 2 | IPR017419 | |
| Domain | DUF5050 | 1.07e-04 | 2 | 194 | 2 | IPR032485 | |
| Domain | DUF5050 | 1.07e-04 | 2 | 194 | 2 | PF16472 | |
| Domain | Na_channel_asu | 1.25e-04 | 10 | 194 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 1.25e-04 | 10 | 194 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 1.25e-04 | 10 | 194 | 3 | PF06512 | |
| Domain | AAA | 1.32e-04 | 144 | 194 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 1.32e-04 | 144 | 194 | 8 | IPR003593 | |
| Domain | IQ | 1.98e-04 | 81 | 194 | 6 | SM00015 | |
| Domain | - | 2.27e-04 | 12 | 194 | 3 | 1.50.10.20 | |
| Domain | GABBAg_rcpt | 3.20e-04 | 3 | 194 | 2 | IPR005437 | |
| Domain | TGF-beta-rel | 3.23e-04 | 32 | 194 | 4 | IPR015615 | |
| Domain | LY | 4.58e-04 | 15 | 194 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 4.58e-04 | 15 | 194 | 3 | IPR000033 | |
| Domain | WD40 | DCAF8 EML6 BRWD3 DCAF8L1 HERC1 CORO7 WDFY1 APAF1 AMBRA1 CFAP43 | 5.10e-04 | 268 | 194 | 10 | SM00320 |
| Domain | TLC | 5.59e-04 | 16 | 194 | 3 | SM00724 | |
| Domain | TLC | 5.59e-04 | 16 | 194 | 3 | PS50922 | |
| Domain | TRAM_LAG1_CLN8 | 5.59e-04 | 16 | 194 | 3 | PF03798 | |
| Domain | TLC-dom | 5.59e-04 | 16 | 194 | 3 | IPR006634 | |
| Domain | TGF-b_C | 5.70e-04 | 37 | 194 | 4 | IPR001839 | |
| Domain | TGF_BETA_1 | 5.70e-04 | 37 | 194 | 4 | PS00250 | |
| Domain | TGFB | 5.70e-04 | 37 | 194 | 4 | SM00204 | |
| Domain | TGF_BETA_2 | 5.70e-04 | 37 | 194 | 4 | PS51362 | |
| Domain | TGF_beta | 5.70e-04 | 37 | 194 | 4 | PF00019 | |
| Domain | WD40_repeat | DCAF8 EML6 BRWD3 DCAF8L1 HERC1 CORO7 WDFY1 APAF1 AMBRA1 CFAP43 | 5.72e-04 | 272 | 194 | 10 | IPR001680 |
| Domain | Sec7_N | 6.35e-04 | 4 | 194 | 2 | IPR032691 | |
| Domain | Sec7_N | 6.35e-04 | 4 | 194 | 2 | PF12783 | |
| Domain | - | 6.35e-04 | 4 | 194 | 2 | 1.20.91.20 | |
| Domain | - | 6.58e-04 | 67 | 194 | 5 | 2.10.90.10 | |
| Domain | Cystine-knot_cytokine | 6.58e-04 | 67 | 194 | 5 | IPR029034 | |
| Domain | Gal_mutarotase_SF_dom | 6.74e-04 | 17 | 194 | 3 | IPR011013 | |
| Domain | C345C | 6.74e-04 | 17 | 194 | 3 | SM00643 | |
| Domain | WD_REPEATS_1 | DCAF8 EML6 BRWD3 DCAF8L1 HERC1 CORO7 WDFY1 APAF1 AMBRA1 CFAP43 | 6.77e-04 | 278 | 194 | 10 | PS00678 |
| Domain | WD_REPEATS_2 | DCAF8 EML6 BRWD3 DCAF8L1 HERC1 CORO7 WDFY1 APAF1 AMBRA1 CFAP43 | 6.96e-04 | 279 | 194 | 10 | PS50082 |
| Domain | WD_REPEATS_REGION | DCAF8 EML6 BRWD3 DCAF8L1 HERC1 CORO7 WDFY1 APAF1 AMBRA1 CFAP43 | 6.96e-04 | 279 | 194 | 10 | PS50294 |
| Domain | - | DCAF8 EML6 BRWD3 DCAF8L1 HERC1 CORO7 WDFY1 APAF1 AMBRA1 CFAP43 PLXNC1 | 7.47e-04 | 333 | 194 | 11 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | DCAF8 EML6 BRWD3 DCAF8L1 HERC1 CORO7 WDFY1 APAF1 AMBRA1 CFAP43 PLXNC1 | 7.84e-04 | 335 | 194 | 11 | IPR015943 |
| Domain | NTR | 9.46e-04 | 19 | 194 | 3 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 9.46e-04 | 19 | 194 | 3 | IPR018933 | |
| Domain | WD40_repeat_dom | DCAF8 EML6 BRWD3 DCAF8L1 HERC1 CORO7 WDFY1 APAF1 AMBRA1 CFAP43 | 1.12e-03 | 297 | 194 | 10 | IPR017986 |
| Domain | Neurotransmitter_ion_chnl_CS | 1.21e-03 | 45 | 194 | 4 | IPR018000 | |
| Domain | Neurotrans-gated_channel_TM | 1.42e-03 | 47 | 194 | 4 | IPR006029 | |
| Domain | - | 1.42e-03 | 47 | 194 | 4 | 2.70.170.10 | |
| Domain | Neur_chan_LBD | 1.42e-03 | 47 | 194 | 4 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 1.42e-03 | 47 | 194 | 4 | PS00236 | |
| Domain | Neur_channel | 1.42e-03 | 47 | 194 | 4 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 1.42e-03 | 47 | 194 | 4 | IPR006202 | |
| Domain | Na_trans_cytopl | 1.57e-03 | 6 | 194 | 2 | PF11933 | |
| Domain | Glyco_hydro_31_AS | 1.57e-03 | 6 | 194 | 2 | IPR030458 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 6.54e-12 | 27 | 153 | 9 | M47755 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 6.79e-10 | 43 | 153 | 9 | M47669 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 1.05e-09 | 45 | 153 | 9 | M47670 | |
| Pathway | BIOCARTA_LIS1_PATHWAY | 1.45e-06 | 19 | 153 | 5 | M22005 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LEWIS_X_ANTIGEN_BIOSYNTHESIS | 1.23e-05 | 5 | 153 | 3 | M47966 | |
| Pathway | BIOCARTA_AMAN_PATHWAY | 1.66e-05 | 15 | 153 | 4 | M22009 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 4.25e-05 | 7 | 153 | 3 | MM14685 | |
| Pathway | WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION | 5.30e-05 | 38 | 153 | 5 | M39854 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 6.75e-05 | 8 | 153 | 3 | M27031 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 1.94e-04 | 11 | 153 | 3 | MM1430 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 2.57e-04 | 12 | 153 | 3 | MM1368 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 3.31e-04 | 13 | 153 | 3 | M4732 | |
| Pubmed | 1.60e-17 | 14 | 208 | 9 | 9373155 | ||
| Pubmed | 2.96e-13 | 7 | 208 | 6 | 9256245 | ||
| Pubmed | 1.52e-10 | 7 | 208 | 5 | 31178125 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 1.24e-09 | 4 | 208 | 4 | 10469592 | |
| Pubmed | 1.24e-09 | 4 | 208 | 4 | 7983737 | ||
| Pubmed | 5.58e-09 | 12 | 208 | 5 | 14557543 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-19 ERVK-24 ERVK-8 ERVK-5 | 5.64e-09 | 94 | 208 | 9 | 21542922 |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 6.19e-09 | 5 | 208 | 4 | 12629516 | |
| Pubmed | Neurons under T Cell Attack Coordinate Phagocyte-Mediated Synaptic Stripping. | 8.54e-08 | 8 | 208 | 4 | 30173917 | |
| Pubmed | Genetic polymorphism of murine C3 controlled by a single co-dominant locus on chromosome 17. | 2.11e-07 | 3 | 208 | 3 | 681746 | |
| Pubmed | Eleven residues determine the acyl chain specificity of ceramide synthases. | 2.11e-07 | 3 | 208 | 3 | 29632068 | |
| Pubmed | 2.11e-07 | 3 | 208 | 3 | 8524789 | ||
| Pubmed | Immune complex glomerulonephritis in C4- and C3-deficient mice. | 2.11e-07 | 3 | 208 | 3 | 9461092 | |
| Pubmed | Regulation of the B cell response to T-dependent antigens by classical pathway complement. | 2.11e-07 | 3 | 208 | 3 | 8752901 | |
| Pubmed | Complement genes contribute sex-biased vulnerability in diverse disorders. | 2.11e-07 | 3 | 208 | 3 | 32499649 | |
| Pubmed | Role of complement in a murine model of peanut-induced anaphylaxis. | 2.11e-07 | 3 | 208 | 3 | 23182714 | |
| Pubmed | 2.11e-07 | 3 | 208 | 3 | 29617048 | ||
| Pubmed | 2.11e-07 | 3 | 208 | 3 | 35017157 | ||
| Pubmed | 2.11e-07 | 3 | 208 | 3 | 14500686 | ||
| Pubmed | In vitro C3 deposition on Cryptococcus capsule occurs via multiple complement activation pathways. | 2.11e-07 | 3 | 208 | 3 | 21723612 | |
| Pubmed | 2.11e-07 | 3 | 208 | 3 | 9829481 | ||
| Pubmed | 2.11e-07 | 3 | 208 | 3 | 16893076 | ||
| Pubmed | 2.11e-07 | 3 | 208 | 3 | 37234916 | ||
| Pubmed | Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli. | 2.11e-07 | 3 | 208 | 3 | 11433344 | |
| Pubmed | 2.11e-07 | 3 | 208 | 3 | 9218619 | ||
| Pubmed | 3.73e-07 | 47 | 208 | 6 | 8812413 | ||
| Pubmed | Impaired mast cell-dependent natural immunity in complement C3-deficient mice. | 8.40e-07 | 4 | 208 | 3 | 9367154 | |
| Pubmed | Complement C4 is protective for lupus disease independent of C3. | 8.40e-07 | 4 | 208 | 3 | 11801636 | |
| Pubmed | 8.40e-07 | 4 | 208 | 3 | 10934224 | ||
| Pubmed | Mutations in dynein genes in patients affected by isolated non-syndromic asthenozoospermia. | 8.40e-07 | 4 | 208 | 3 | 18492703 | |
| Pubmed | Intestinal reperfusion injury is mediated by IgM and complement. | 8.40e-07 | 4 | 208 | 3 | 10066708 | |
| Pubmed | 8.40e-07 | 4 | 208 | 3 | 15477230 | ||
| Pubmed | Phylogeny of the C3/C4/C5 complement-component gene family indicates that C5 diverged first. | 8.40e-07 | 4 | 208 | 3 | 8015436 | |
| Pubmed | 8.40e-07 | 4 | 208 | 3 | 15102802 | ||
| Pubmed | Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells. | 8.40e-07 | 4 | 208 | 3 | 16304047 | |
| Pubmed | Efficient amyloid A clearance in the absence of immunoglobulins and complement factors. | 8.40e-07 | 4 | 208 | 3 | 23454183 | |
| Pubmed | The human complement system: assembly of the classical pathway C3 convertase. | 8.40e-07 | 4 | 208 | 3 | 6906228 | |
| Pubmed | Functional analysis of Ficolin-3 mediated complement activation. | 8.40e-07 | 4 | 208 | 3 | 21085669 | |
| Pubmed | 8.40e-07 | 4 | 208 | 3 | 9409643 | ||
| Pubmed | Macrophage-derived complement component C4 can restore humoral immunity in C4-deficient mice. | 8.40e-07 | 4 | 208 | 3 | 12421924 | |
| Pubmed | Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis. | 8.40e-07 | 4 | 208 | 3 | 30301856 | |
| Pubmed | Allelic distribution of complement components BF, C4A, C4B, and C3 in Psoriasis vulgaris. | 8.40e-07 | 4 | 208 | 3 | 11803045 | |
| Pubmed | 8.40e-07 | 4 | 208 | 3 | 19302245 | ||
| Pubmed | Evidence for non-traditional activation of complement factor C3 during murine liver regeneration. | 8.40e-07 | 4 | 208 | 3 | 18452991 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NDOR1 GBF1 MFHAS1 TMEM187 DYSF STK11IP ACOX3 TBC1D24 BMP4 MDN1 HERC1 RHBDF1 EP400 UBE3B AMBRA1 CFAP43 ARHGAP35 TBC1D17 AATK RPAP1 CCDC34 MARK4 | 9.30e-07 | 1105 | 208 | 22 | 35748872 |
| Pubmed | 2.09e-06 | 5 | 208 | 3 | 16783845 | ||
| Pubmed | 2.09e-06 | 5 | 208 | 3 | 18056835 | ||
| Pubmed | 2.09e-06 | 5 | 208 | 3 | 21707943 | ||
| Pubmed | 2.09e-06 | 5 | 208 | 3 | 7514554 | ||
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 2.09e-06 | 5 | 208 | 3 | 11401426 | |
| Pubmed | 2.09e-06 | 5 | 208 | 3 | 15192652 | ||
| Pubmed | 2.09e-06 | 5 | 208 | 3 | 39056782 | ||
| Pubmed | 2.09e-06 | 5 | 208 | 3 | 9382884 | ||
| Pubmed | Protective T cell-independent antiviral antibody responses are dependent on complement. | 2.09e-06 | 5 | 208 | 3 | 10523614 | |
| Pubmed | Stromal complement receptor CD21/35 facilitates lymphoid prion colonization and pathogenesis. | 2.09e-06 | 5 | 208 | 3 | 17947689 | |
| Pubmed | Mammalian Lass6 and its related family members regulate synthesis of specific ceramides. | 2.09e-06 | 5 | 208 | 3 | 15823095 | |
| Pubmed | 2.09e-06 | 5 | 208 | 3 | 22689574 | ||
| Pubmed | Distinct human α(1,3)-fucosyltransferases drive Lewis-X/sialyl Lewis-X assembly in human cells. | 2.09e-06 | 5 | 208 | 3 | 29593094 | |
| Pubmed | Predominant role for C5b-9 in renal ischemia/reperfusion injury. | 2.09e-06 | 5 | 208 | 3 | 10811844 | |
| Pubmed | Intranasal peptide-induced tolerance and linked suppression: consequences of complement deficiency. | 2.09e-06 | 5 | 208 | 3 | 25039245 | |
| Pubmed | 2.09e-06 | 5 | 208 | 3 | 19710463 | ||
| Pubmed | 2.09e-06 | 5 | 208 | 3 | 26887952 | ||
| Pubmed | 2.09e-06 | 5 | 208 | 3 | 29743491 | ||
| Pubmed | Formation of high affinity C5 convertase of the classical pathway of complement. | 2.09e-06 | 5 | 208 | 3 | 12878586 | |
| Pubmed | Complement C4A Regulates Autoreactive B Cells in Murine Lupus. | 2.09e-06 | 5 | 208 | 3 | 33147456 | |
| Pubmed | 3.56e-06 | 18 | 208 | 4 | 18664271 | ||
| Pubmed | 4.16e-06 | 6 | 208 | 3 | 15597324 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 4.16e-06 | 6 | 208 | 3 | 23652591 | |
| Pubmed | 4.16e-06 | 6 | 208 | 3 | 19710450 | ||
| Pubmed | Burn injury reveals altered phenotype in mannan-binding lectin-deficient mice. | 4.16e-06 | 6 | 208 | 3 | 17363917 | |
| Pubmed | 4.16e-06 | 6 | 208 | 3 | 18820683 | ||
| Pubmed | 4.16e-06 | 6 | 208 | 3 | 23936132 | ||
| Pubmed | 4.16e-06 | 6 | 208 | 3 | 15063128 | ||
| Pubmed | 4.16e-06 | 6 | 208 | 3 | 17977534 | ||
| Pubmed | 4.16e-06 | 6 | 208 | 3 | 16615889 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | MYH11 LMF2 GANAB EIF3L CORO7 MAP3K7 TOR1AIP2 NCAPD3 CANX POLR2B DNAH2 NUP98 ARFGEF1 RANBP6 TARS2 SLC4A2 CERS5 RPAP1 KIRREL1 | 4.44e-06 | 942 | 208 | 19 | 31073040 |
| Pubmed | 7.25e-06 | 7 | 208 | 3 | 20139276 | ||
| Pubmed | 7.25e-06 | 7 | 208 | 3 | 22037602 | ||
| Pubmed | 7.25e-06 | 7 | 208 | 3 | 29233958 | ||
| Pubmed | 7.25e-06 | 7 | 208 | 3 | 12055255 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | GBF1 EML6 PPM1M PTPRH HERC1 DNAH8 ZCCHC18 TNC CANX DNAH7 AATK LRP1 | 9.73e-06 | 420 | 208 | 12 | 28065597 |
| Pubmed | 1.15e-05 | 8 | 208 | 3 | 26110920 | ||
| Pubmed | Divergent immunoglobulin g subclass activity through selective Fc receptor binding. | 1.15e-05 | 8 | 208 | 3 | 16322460 | |
| Pubmed | Impaired antibody response causes persistence of prototypic T cell-contained virus. | 1.15e-05 | 8 | 208 | 3 | 19355789 | |
| Pubmed | 1.15e-05 | 8 | 208 | 3 | 24474777 | ||
| Pubmed | The role of complement in cryoglobulin-induced immune complex glomerulonephritis. | 1.15e-05 | 8 | 208 | 3 | 16272350 | |
| Pubmed | 1.15e-05 | 8 | 208 | 3 | 20870940 | ||
| Pubmed | 1.15e-05 | 8 | 208 | 3 | 28301559 | ||
| Pubmed | 1.15e-05 | 8 | 208 | 3 | 14670299 | ||
| Pubmed | The TGFβ type I receptor TGFβRI functions as an inhibitor of BMP signaling in cartilage. | 1.68e-05 | 26 | 208 | 4 | 31311865 | |
| Pubmed | Surviving mousepox infection requires the complement system. | 1.72e-05 | 9 | 208 | 3 | 19112490 | |
| Pubmed | 1.72e-05 | 9 | 208 | 3 | 16382098 | ||
| Pubmed | Targeted inactivation of the mouse alpha 2-macroglobulin gene. | 1.72e-05 | 9 | 208 | 3 | 7544347 | |
| Pubmed | 1.83e-05 | 187 | 208 | 8 | 26460568 | ||
| Pubmed | GBF1 ILK DCAF8 PACSIN3 STAT1 MDN1 SMG7 RIMBP3C USP48 NCAPD3 PPFIBP1 CANX ARHGAP35 ROCK1 DNAH11 | 1.95e-05 | 689 | 208 | 15 | 36543142 | |
| Pubmed | 1.99e-05 | 55 | 208 | 5 | 15342483 | ||
| Pubmed | Developmental gene expression profiling along the tonotopic axis of the mouse cochlea. | 2.27e-05 | 28 | 208 | 4 | 22808246 | |
| Pubmed | Functional modifications of acid-sensing ion channels by ligand-gated chloride channels. | 2.45e-05 | 10 | 208 | 3 | 21789198 | |
| Pubmed | 2.45e-05 | 10 | 208 | 3 | 30429287 | ||
| Pubmed | 2.45e-05 | 10 | 208 | 3 | 12970426 | ||
| GeneFamily | Dyneins, axonemal | DNAH14 DNAH5 DNAH6 DNAH8 DNAH3 DNAH2 DNAH7 DNAH1 DNAH17 DNAH11 | 1.71e-17 | 17 | 147 | 10 | 536 |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 4.07e-09 | 9 | 147 | 5 | 1234 | |
| GeneFamily | CERS class homeoboxes | 1.03e-05 | 6 | 147 | 3 | 530 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 4.27e-05 | 9 | 147 | 3 | 1203 | |
| GeneFamily | WD repeat domain containing | DCAF8 EML6 BRWD3 DCAF8L1 HERC1 CORO7 WDFY1 APAF1 AMBRA1 CFAP43 | 5.73e-05 | 262 | 147 | 10 | 362 |
| GeneFamily | Fucosyltransferases|Blood group antigens | 1.42e-04 | 13 | 147 | 3 | 434 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 4.64e-04 | 19 | 147 | 3 | 563 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 9.40e-04 | 24 | 147 | 3 | 654 | |
| GeneFamily | Type 1 receptor serine/threonine kinases | 1.34e-03 | 7 | 147 | 2 | 345 | |
| GeneFamily | Prostaglandin (prostanoid) receptors | 2.28e-03 | 9 | 147 | 2 | 207 | |
| GeneFamily | Complement system|Sushi domain containing | 3.09e-03 | 36 | 147 | 3 | 492 | |
| GeneFamily | Low density lipoprotein receptors | 4.83e-03 | 13 | 147 | 2 | 634 | |
| GeneFamily | Tubulin tyrosine ligase family | 5.60e-03 | 14 | 147 | 2 | 779 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | GABRG2 INHBB GART LPCAT4 PTGER1 SMG7 PTPRH FNDC11 SCN2A CACNA1I C4A C4B CERS4 GDF15 NUP98 NLRP1 LRP1 UBA6 KIRREL1 FZD10 MYBPC2 | 5.89e-06 | 909 | 198 | 21 | M41018 |
| ToppCell | 3'-Adult-SmallIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.05e-08 | 197 | 198 | 10 | 1614bc5f41fd2c8385e58ed6b87ef1536421f29a | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.58e-08 | 173 | 198 | 9 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.52e-07 | 185 | 198 | 9 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | (12)_SLC16A7+|World / shred by cell type by condition | 1.99e-07 | 191 | 198 | 9 | e427eeddd2e87c14376a37db0b43f120c90436bc | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.18e-07 | 193 | 198 | 9 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | proximal-Epithelial-Ciliated|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.82e-07 | 199 | 198 | 9 | 9700f06e51ddca85e482b4f9bd4a79bfcd3cfb76 | |
| ToppCell | proximal-3-Epithelial-Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.82e-07 | 199 | 198 | 9 | 1188afad6fd5f01f9aeba225f611f38b237dd2c9 | |
| ToppCell | proximal-Epithelial-Ciliated-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.82e-07 | 199 | 198 | 9 | 2e8ace105c4e2405baa06d953e52888b54e2d055 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-07 | 145 | 198 | 8 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-07 | 200 | 198 | 9 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-07 | 200 | 198 | 9 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.60e-07 | 154 | 198 | 8 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.60e-07 | 154 | 198 | 8 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.60e-07 | 154 | 198 | 8 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.60e-07 | 154 | 198 | 8 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.83e-07 | 155 | 198 | 8 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.83e-07 | 155 | 198 | 8 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.08e-07 | 163 | 198 | 8 | 360cd65decda24853124f33a174f5224d7f3ce23 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.08e-07 | 163 | 198 | 8 | b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.30e-07 | 169 | 198 | 8 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.37e-06 | 178 | 198 | 8 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | BAL-Control-Myeloid-Macrophage-transitional_Macro|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.69e-06 | 183 | 198 | 8 | 79f05b8a967124d831b0baef137e30659f5917a7 | |
| ToppCell | BAL-Control-Myeloid-Macrophage|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.69e-06 | 183 | 198 | 8 | 8e9d45c96b44558158e3d59613f64a73d5390c19 | |
| ToppCell | BAL-Control-Myeloid-Macrophage-transitional_Macro-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.69e-06 | 183 | 198 | 8 | 0408d991ddb639594b45d5cb2432dd29289167b1 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-06 | 184 | 198 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | BAL-Control-Myeloid-Macrophage-transitional_Macro-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.76e-06 | 184 | 198 | 8 | 92202e1cd0bba1ce4b061ebcb8a2af5bb590542a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-06 | 184 | 198 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | BAL-Control-Myeloid-Macrophage-transitional_Macro|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.76e-06 | 184 | 198 | 8 | 337e38a6b2b6770cc992d88b006829f194841b10 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-06 | 184 | 198 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | BAL-Control-Myeloid-Macrophage|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.76e-06 | 184 | 198 | 8 | 7331535d469453a5264dcb0270a97f63d3b55201 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.91e-06 | 186 | 198 | 8 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-06 | 187 | 198 | 8 | e61992de4f98eeea08b43213850769d923f8db48 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-06 | 189 | 198 | 8 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.15e-06 | 189 | 198 | 8 | cd4746ea6ae48a7dd14a2960d38d9445a738cf2c | |
| ToppCell | Control-Myeloid-transitional_Macro|Control / Disease group,lineage and cell class （2021.01.30） | 2.33e-06 | 191 | 198 | 8 | 3ed0b1ff628a165e3c92c2e493206015f57dccfe | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.93e-06 | 197 | 198 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.93e-06 | 197 | 198 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.15e-06 | 199 | 198 | 8 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.15e-06 | 199 | 198 | 8 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.27e-06 | 200 | 198 | 8 | 85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.27e-06 | 200 | 198 | 8 | 12bc7d95c4166d12487081a76d210b7abe5991b0 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.55e-06 | 148 | 198 | 7 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.55e-06 | 148 | 198 | 7 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.43e-06 | 156 | 198 | 7 | 203ef22eb76bd2b829b027c30af0557080f4006c | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-06 | 160 | 198 | 7 | 0544bc465af208da448858d6e174ff56f2e08a46 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte-3|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 174 | 198 | 7 | 76310c0af1d7df6a4de3816838b2ac2892f68746 | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Control / Condition, Lineage and Cell class | 1.31e-05 | 174 | 198 | 7 | 4c64ff5666812fb4efa440ba4faeca51d916d68e | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.52e-05 | 178 | 198 | 7 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-05 | 179 | 198 | 7 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-05 | 180 | 198 | 7 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-05 | 181 | 198 | 7 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 1.75e-05 | 182 | 198 | 7 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-05 | 184 | 198 | 7 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-05 | 184 | 198 | 7 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-05 | 184 | 198 | 7 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | Ciliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.88e-05 | 184 | 198 | 7 | 07c5a9633ccdcd18771e3230d6198a55c400afa6 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.95e-05 | 185 | 198 | 7 | ae966929fb5bbb08ffcbac76cb21941638727f55 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.95e-05 | 185 | 198 | 7 | 3beebaa92275086b1fae5f8c0c3d54016c5ba2aa | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.95e-05 | 185 | 198 | 7 | 42939b294ea3e871274d8b73124c850dc1904fd2 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.95e-05 | 185 | 198 | 7 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 1.95e-05 | 185 | 198 | 7 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.95e-05 | 185 | 198 | 7 | 7a3612520ae4f0cd61480eadba31eecce001419d | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.95e-05 | 185 | 198 | 7 | ceff11cfa679147ccfd0a0f8079e697a6bea34d9 | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.95e-05 | 185 | 198 | 7 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 1.95e-05 | 185 | 198 | 7 | 0998b6bf44287eebbf39249fff23fc3689e44c4e | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.95e-05 | 185 | 198 | 7 | 9aea5ed8f9cee5ee933891203aac7adb85d68201 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.95e-05 | 185 | 198 | 7 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | Severe_COVID-19-Myeloid-transitional_Macro|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.95e-05 | 185 | 198 | 7 | f7ef0d7740b4cfedc38846e802898c402dc411fd | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.02e-05 | 186 | 198 | 7 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.09e-05 | 187 | 198 | 7 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.09e-05 | 187 | 198 | 7 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 2.16e-05 | 188 | 198 | 7 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.16e-05 | 188 | 198 | 7 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.24e-05 | 189 | 198 | 7 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 2.24e-05 | 189 | 198 | 7 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.24e-05 | 189 | 198 | 7 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 2.31e-05 | 190 | 198 | 7 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.39e-05 | 191 | 198 | 7 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.39e-05 | 191 | 198 | 7 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.39e-05 | 191 | 198 | 7 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.39e-05 | 191 | 198 | 7 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.39e-05 | 191 | 198 | 7 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.39e-05 | 191 | 198 | 7 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.39e-05 | 191 | 198 | 7 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.39e-05 | 191 | 198 | 7 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.39e-05 | 191 | 198 | 7 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.47e-05 | 192 | 198 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Ciliated-cil-3|World / Class top | 2.47e-05 | 192 | 198 | 7 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 2.47e-05 | 192 | 198 | 7 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.56e-05 | 193 | 198 | 7 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.56e-05 | 193 | 198 | 7 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-05 | 193 | 198 | 7 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.64e-05 | 194 | 198 | 7 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.64e-05 | 194 | 198 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.64e-05 | 194 | 198 | 7 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.64e-05 | 194 | 198 | 7 | b0477583301dc6d9767b667bd2f8f94fbfaa6f81 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 2.64e-05 | 194 | 198 | 7 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.73e-05 | 195 | 198 | 7 | cfcf554b436083179dea1d6fd6e3a800ea2430fe | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.73e-05 | 195 | 198 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.73e-05 | 195 | 198 | 7 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| Drug | Biliton | 1.32e-06 | 41 | 196 | 6 | CID000002974 | |
| Drug | IC261 | 1.81e-06 | 96 | 196 | 8 | CID000003674 | |
| Drug | prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HG-U133A | ILK GART POGLUT1 NCR1 NCAPD3 GDF15 PPFIBP1 NUP98 AMBRA1 MYO15A | 7.09e-06 | 193 | 196 | 10 | 455_UP |
| Drug | Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; HL60; HG-U133A | 7.76e-06 | 195 | 196 | 10 | 1371_DN | |
| Drug | AC1L4GYE | 1.23e-05 | 6 | 196 | 3 | CID000156861 | |
| Drug | vanadyl | STAT1 PLD2 NCR1 DNAH5 DNAH8 DNAH3 RHBDF1 ARFGEF1 DNAH1 DNAH17 G6PC1 DNAH11 | 1.53e-05 | 307 | 196 | 12 | CID000061671 |
| Disease | Febrile Convulsions | 2.09e-07 | 9 | 191 | 4 | C0009952 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 2.09e-07 | 9 | 191 | 4 | C3502809 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 8.09e-07 | 12 | 191 | 4 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 4.85e-06 | 18 | 191 | 4 | HP_0002373 | |
| Disease | Seizure, Febrile, Simple | 9.17e-06 | 7 | 191 | 3 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 9.17e-06 | 7 | 191 | 3 | C0751057 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 3.10e-05 | 10 | 191 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 3.10e-05 | 10 | 191 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | fibrodysplasia ossificans progressiva (implicated_via_orthology) | 4.17e-05 | 2 | 191 | 2 | DOID:13374 (implicated_via_orthology) | |
| Disease | Infantile Severe Myoclonic Epilepsy | 7.28e-05 | 13 | 191 | 3 | C0751122 | |
| Disease | Epilepsy | 7.92e-05 | 109 | 191 | 6 | C0014544 | |
| Disease | epilepsy (implicated_via_orthology) | 9.70e-05 | 163 | 191 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | Familial Testotoxicosis | 1.25e-04 | 3 | 191 | 2 | C0342549 | |
| Disease | Epilepsy, Cryptogenic | 1.97e-04 | 82 | 191 | 5 | C0086237 | |
| Disease | Awakening Epilepsy | 1.97e-04 | 82 | 191 | 5 | C0751111 | |
| Disease | Aura | 1.97e-04 | 82 | 191 | 5 | C0236018 | |
| Disease | alpha-(1;3)-fucosyltransferase 5 measurement | 2.48e-04 | 4 | 191 | 2 | EFO_0021979 | |
| Disease | Kartagener syndrome (is_implicated_in) | 2.48e-04 | 4 | 191 | 2 | DOID:0050144 (is_implicated_in) | |
| Disease | Immunologic Deficiency Syndromes | 4.30e-04 | 23 | 191 | 3 | C0021051 | |
| Disease | Lennox-Gastaut syndrome | 6.15e-04 | 6 | 191 | 2 | C0238111 | |
| Disease | glucagon measurement, glucose tolerance test | 6.15e-04 | 6 | 191 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | Idiopathic generalized epilepsy | 6.15e-04 | 6 | 191 | 2 | C0270850 | |
| Disease | Ciliopathies | 7.62e-04 | 110 | 191 | 5 | C4277690 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 8.57e-04 | 7 | 191 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | toxic shock syndrome (implicated_via_orthology) | 8.57e-04 | 7 | 191 | 2 | DOID:14115 (implicated_via_orthology) | |
| Disease | galactoside 3(4)-L-fucosyltransferase measurement | 8.57e-04 | 7 | 191 | 2 | EFO_0021853 | |
| Disease | alpha-(1,3)-fucosyltransferase 5 measurement | 8.57e-04 | 7 | 191 | 2 | EFO_0020136 | |
| Disease | atrioventricular septal defect (implicated_via_orthology) | 8.57e-04 | 7 | 191 | 2 | DOID:0050651 (implicated_via_orthology) | |
| Disease | osteoarthritis, hip, body mass index | 9.53e-04 | 30 | 191 | 3 | EFO_0004340, EFO_1000786 | |
| Disease | cortical thickness | A2M DYSF STAT1 STAB1 BMP4 BPGM SMG7 ZSWIM4 PDGFC MAP3K7 FNIP2 PPFIBP1 XKR6 ARHGAP35 PLXNC1 LRP1 MACF1 | 9.64e-04 | 1113 | 191 | 17 | EFO_0004840 |
| Disease | susceptibility to mononucleosis measurement | 1.06e-03 | 69 | 191 | 4 | EFO_0008403 | |
| Disease | NEPHRONOPHTHISIS 2 | 1.14e-03 | 8 | 191 | 2 | C1865872 | |
| Disease | X-17676 measurement | 1.14e-03 | 8 | 191 | 2 | EFO_0800785 | |
| Disease | Complement deficiency disease | 1.26e-03 | 33 | 191 | 3 | C0272242 | |
| Disease | reticulocyte count | NDOR1 SWAP70 EML6 ACVR1 STAT1 FFAR4 SLC12A5 BPGM PTPRH TMC8 C4B HERC1 PDGFC USP48 DNAH17 MARK4 | 1.32e-03 | 1045 | 191 | 16 | EFO_0007986 |
| Disease | lymphocyte count | GBF1 EML6 TMEM187 ACVRL1 LINC02908 BPGM PTPRH C3 CORO7 PDGFC FNIP2 GLT6D1 MMS22L CANX SCML4 CERS5 CD38 DNAH17 MARK4 KIRREL1 | 1.36e-03 | 1464 | 191 | 20 | EFO_0004587 |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 1.46e-03 | 9 | 191 | 2 | C0085548 | |
| Disease | Primary ciliary dyskinesia | 1.63e-03 | 36 | 191 | 3 | cv:C0008780 | |
| Disease | Carotid Circulation Transient Ischemic Attack | 1.81e-03 | 10 | 191 | 2 | C0751019 | |
| Disease | Transient Ischemic Attack | 1.81e-03 | 10 | 191 | 2 | C0007787 | |
| Disease | Crescendo Transient Ischemic Attacks | 1.81e-03 | 10 | 191 | 2 | C0751021 | |
| Disease | Transient Ischemic Attack, Vertebrobasilar Circulation | 1.81e-03 | 10 | 191 | 2 | C0751020 | |
| Disease | Brain Stem Ischemia, Transient | 1.81e-03 | 10 | 191 | 2 | C0751022 | |
| Disease | Posterior Circulation Transient Ischemic Attack | 1.81e-03 | 10 | 191 | 2 | C0472381 | |
| Disease | Epilepsy, Myoclonic, Infantile | 1.81e-03 | 10 | 191 | 2 | C0917800 | |
| Disease | Transient Ischemic Attack, Anterior Circulation | 1.81e-03 | 10 | 191 | 2 | C1527335 | |
| Disease | Transient Cerebral Ischemia | 1.81e-03 | 10 | 191 | 2 | C0917805 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 1.96e-03 | 346 | 191 | 8 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.99e-03 | 200 | 191 | 6 | EFO_0004611, EFO_0020945 | |
| Disease | Colorectal Carcinoma | TTLL3 SLC12A5 BMP4 ACTL9 NCR1 PZP DNAH8 DNAH3 ARFGEF1 ITPRID1 RPAP1 LRP1 | 2.18e-03 | 702 | 191 | 12 | C0009402 |
| Disease | neuroticism measurement, response to selective serotonin reuptake inhibitor | 2.21e-03 | 11 | 191 | 2 | EFO_0005658, EFO_0007660 | |
| Disease | quality of life during menstruation measurement, dysmenorrheic pain measurement | 2.21e-03 | 11 | 191 | 2 | EFO_0007889, EFO_0009366 | |
| Disease | Myoclonic Astatic Epilepsy | 2.21e-03 | 11 | 191 | 2 | C0393702 | |
| Disease | systemic lupus erythematosus | MFHAS1 TMEM187 STAT1 SMG7 PTPRH SCN10A C3 C4B PLD2 GDF15 CHD9 XKR6 TRMT44 | 2.21e-03 | 799 | 191 | 13 | MONDO_0007915 |
| Disease | epilepsy | 2.37e-03 | 41 | 191 | 3 | EFO_0000474 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.59e-03 | 145 | 191 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | candidiasis (implicated_via_orthology) | 2.91e-03 | 44 | 191 | 3 | DOID:1508 (implicated_via_orthology) | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 2.99e-03 | 150 | 191 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | Primary Ciliary Dyskinesia | 3.51e-03 | 47 | 191 | 3 | C4551720 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 3.60e-03 | 14 | 191 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 3.97e-03 | 99 | 191 | 4 | DOID:11446 (biomarker_via_orthology) | |
| Disease | MMR-related febrile seizures | 4.14e-03 | 15 | 191 | 2 | EFO_0006519 | |
| Disease | serum alanine aminotransferase measurement | GBF1 MFHAS1 CYP8B1 ETV6 TMEM187 SERINC2 USP48 DNAH2 ARHGAP39 XKR6 TARS2 TRMT44 MARK4 | 4.50e-03 | 869 | 191 | 13 | EFO_0004735 |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 4.71e-03 | 16 | 191 | 2 | C0393706 | |
| Disease | cystatin C measurement | 4.85e-03 | 402 | 191 | 8 | EFO_0004617 | |
| Disease | muscular dystrophy (is_implicated_in) | 5.32e-03 | 17 | 191 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Antibody Deficiency Syndrome | 5.32e-03 | 17 | 191 | 2 | C0003257 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 5.32e-03 | 17 | 191 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 5.32e-03 | 17 | 191 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 5.32e-03 | 17 | 191 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 5.32e-03 | 17 | 191 | 2 | C0751780 | |
| Disease | May-White Syndrome | 5.32e-03 | 17 | 191 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 5.32e-03 | 17 | 191 | 2 | C0751781 | |
| Disease | refractive error | 5.52e-03 | 326 | 191 | 7 | MONDO_0004892 | |
| Disease | wellbeing measurement | MFHAS1 CHD2 ACVRL1 SLC12A5 STAB1 HERC1 TBC1D21 MMS22L UBE3B XKR6 AATK | 5.64e-03 | 692 | 191 | 11 | EFO_0007869 |
| Disease | Action Myoclonus-Renal Failure Syndrome | 5.96e-03 | 18 | 191 | 2 | C0751779 | |
| Disease | heart rate response to recovery post exercise | 6.04e-03 | 57 | 191 | 3 | EFO_0009185 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PRSLLILDDVWDSWV | 236 | O14727 | |
| PEWLISEDWALLQAV | 2366 | Q96L91 | |
| QEPQWRETARWIKFE | 336 | P04920 | |
| WKPRAWVLEASVQSA | 1161 | Q5SNV9 | |
| LPEFELALWNWESSI | 131 | Q8NDM7 | |
| QDRFWLPPNVTWTEL | 11 | Q9HA82 | |
| IQGIAIIVYRLPWTW | 61 | Q53TN4 | |
| DIPVRSFFPENWLWR | 771 | P0C0L5 | |
| NWLWRVETVDRFQIL | 781 | P0C0L5 | |
| VLERASWWPEFSVNK | 676 | O15254 | |
| RVWVRGWFPILFELS | 1376 | Q9Y6D6 | |
| RVDIWAFGLVLWEVA | 401 | Q04771 | |
| SGIVVDWDAAELIWR | 116 | Q8TC94 | |
| QDFWDDSIPDIIPRW | 146 | C9JDP6 | |
| IVSRSEFPESWLWNV | 761 | P01024 | |
| LDTWTQDLTLPAVVW | 4361 | Q96DT5 | |
| EWFAPQWILDTIPRR | 921 | Q6RI45 | |
| TDIWAFGLVLWEIAR | 396 | P37023 | |
| WPGTFSFIIETWREE | 116 | Q9NYJ7 | |
| FPWQCVLVAEEVVWR | 1506 | Q96M86 | |
| RLQWWDFTKFDLPEI | 861 | Q9C0C7 | |
| QLLPPTYRDVWLEWS | 456 | Q7Z478 | |
| RWETFDVSPAVLRWT | 211 | P12644 | |
| WERLWLPVNLTWADL | 11 | Q96G23 | |
| WILNTTLFESWEIIG | 291 | Q8N5B7 | |
| VRKYFPETWIWDLVV | 731 | P01023 | |
| VVVLAVVVPRWRQQW | 36 | P28907 | |
| WDWLANITEIQEPLA | 81 | O95156 | |
| FPETWIWELVAVNSS | 741 | P20742 | |
| TDWRLILDWVPYING | 36 | O14957 | |
| IKRTSENQWWELFDP | 61 | Q9C0H5 | |
| VEVRLPWDLLQVYWG | 1056 | A6NNM3 | |
| VEVRLPWDLLQVYWG | 1056 | A6NJZ7 | |
| WDVEKDAPLFRNWAI | 46 | P14316 | |
| ELVPQDLWAAKAWLI | 16 | Q9NVR2 | |
| TVLVWRLVAVEENVW | 71 | Q9NRA1 | |
| LFREDLVRSAAQWPW | 186 | Q8NBL1 | |
| LQPIYWSRDDVAQWL | 56 | P41212 | |
| LLWASVLFLAPEDWA | 301 | Q08AI8 | |
| EWAPQNLTRWTFEKA | 71 | Q9H496 | |
| LESEGLWEWAIFVLL | 1556 | P52948 | |
| DQLAWLWAESTALFP | 236 | Q12891 | |
| QPLWKSVWRFLRDLE | 1151 | O00370 | |
| SVFRELWDWSVCVPL | 161 | Q9NU22 | |
| ILFWTDWDANFPRIE | 1391 | Q9NZR2 | |
| LWPFAWLQVAGLSEE | 61 | Q643R3 | |
| LVALVWFLVEDWLSR | 266 | O76036 | |
| TWDDLRWSIPTILEF | 581 | Q2M2H8 | |
| NIWTAWQAITPLVEE | 951 | Q9Y4C4 | |
| QSIPEWLEFWEIDPV | 131 | Q6ZRS4 | |
| WLEFWEIDPVEILLD | 136 | Q6ZRS4 | |
| WARVALVTAPQDLWV | 181 | Q02846 | |
| LNLLTVWDWSVQFEP | 516 | Q9C0I1 | |
| FNWVTRWLDDIGLPQ | 721 | Q86W92 | |
| LWFRRVLWDQPLKFE | 3291 | Q9UKN7 | |
| LELPNQWLWDIIDEF | 176 | Q9Y262 | |
| VIQSRDPLGFSWWII | 341 | Q6ZRQ5 | |
| LFWTDWDASLPRIEA | 1401 | Q07954 | |
| FAQWDGPTVVSWLEL | 826 | O75335 | |
| DFRLIGWNDWIIAPT | 311 | P09529 | |
| VLFLWEHVPAWSVVL | 306 | Q8N3F9 | |
| ILVWVWPFGQTFDLT | 66 | Q9Y231 | |
| PAQSWVWLVDLERTI | 1131 | Q15751 | |
| TAVIWEPVLSAEAWL | 831 | P57737 | |
| AIPLVLAVRWTEAWL | 91 | Q5NUL3 | |
| EDWLLWQVPEFSTVA | 1186 | O60486 | |
| WWKLFTTVRPLIEVQ | 1236 | Q92614 | |
| AVRLASWNQILDPWV | 336 | P34995 | |
| SWNQILDPWVYILLR | 341 | P34995 | |
| LFRWVPVTDAYWQIL | 786 | Q9C000 | |
| IGIEPWRTRFDLWNK | 126 | Q5W188 | |
| FWEEATPIWITNQRA | 116 | Q9UJA9 | |
| KVVVWDWVRRQPVLD | 216 | Q5TAQ9 | |
| DWFSRWPREALIAVA | 2976 | Q96JB1 | |
| PVIQWFWEVVEDITQ | 811 | Q8IYU2 | |
| DVFSWGIILWEVITR | 211 | O43318 | |
| VIEILFSWTVWFPED | 131 | Q9UJY4 | |
| FSWTVWFPEDIKIRD | 136 | Q9UJY4 | |
| WVSFWISQAAVPARV | 266 | O14764 | |
| VRASLEDLGWADWVL | 216 | Q99988 | |
| TAWLILEELGQEWVP | 66 | P07738 | |
| VPQWVITIIIWLFFL | 431 | Q96P66 | |
| AVDPWLRDLWDRVLG | 141 | Q9UHB4 | |
| WITIIRARFEEVLTW | 6851 | Q9UPN3 | |
| VASVTWFLVLARVAW | 161 | Q86SM5 | |
| WEVPFEEISELQWLG | 161 | O43283 | |
| LRFWAFAEAEALPWA | 91 | Q8TEZ7 | |
| LVVPELSWELDIWAQ | 336 | Q86YG4 | |
| REDKRFAVVWLAIWA | 221 | Q9ULW2 | |
| VWNDWAIIKAALEPF | 81 | P87889 | |
| VWNDWAIIKAALEPF | 81 | Q9YNA8 | |
| VWNDWAIIKAALEPF | 81 | P62683 | |
| VWNDWAIIKAALEPF | 81 | P63145 | |
| VWNDWAIIKAALEPF | 81 | Q9HDB9 | |
| VWNDWAIIKAALEPF | 81 | Q7LDI9 | |
| VWNDWAIIKAALEPF | 81 | P63130 | |
| VWNDWAIIKAALEPF | 81 | P62685 | |
| VWNDWAIIKAALEPF | 81 | P63126 | |
| VWNDWAIIKAALEPF | 81 | P62684 | |
| ELIEPWFIFSLIWSV | 2101 | Q9P2D7 | |
| PLSTIANWEREFRTW | 916 | Q3L8U1 | |
| IDWFVQWPREALLSV | 2601 | Q9C0G6 | |
| ENIFWPELKQITWLS | 146 | O60725 | |
| RLPESRLTPWEVWFI | 136 | Q96HJ3 | |
| QIWWTTEVGLAFARL | 1701 | Q9UFH2 | |
| DRKWIIFDGPVDAIW | 1786 | Q8TD57 | |
| APQWLSEKAWAEIVR | 3411 | Q8TD57 | |
| VLSWVSFWINKDAVP | 286 | Q8N1C3 | |
| WLAPVLWEGTFDRRV | 51 | Q7Z4J2 | |
| TSWQREFEIWAPEIN | 546 | O14647 | |
| LLWVAVIGDWLNLVF | 61 | P35575 | |
| ARDLVWSQAWPDPDV | 36 | Q6ZV77 | |
| QDWARLRWFVTIQPA | 221 | Q9BVV2 | |
| IWNLYSVPRIAEPVW | 386 | Q9P278 | |
| AWIVIFQVITLEGWV | 346 | Q9P0X4 | |
| IQWLEAEIIPDGWFS | 126 | Q12841 | |
| RKWLIFDGPVDAVWI | 1686 | Q8WXX0 | |
| WVSFWINKDAVPART | 291 | P18507 | |
| WSFAVLLWELVTREV | 376 | Q13418 | |
| AAEERPWLWVVYILT | 476 | P27824 | |
| TEKLWRNALEAWAVP | 256 | P51993 | |
| NFDWQWIILDGPVDT | 1566 | Q0VDD8 | |
| WIILDGPVDTFWVEN | 1571 | Q0VDD8 | |
| IDWYERWPEEALLIV | 2166 | Q0VDD8 | |
| VDIWSFGVVLWELLT | 291 | Q12852 | |
| LQNFVPIDLDEWWAQ | 136 | Q9BUT9 | |
| PIDLDEWWAQQFLAR | 141 | Q9BUT9 | |
| WFRVELTIPEAWVGQ | 81 | Q9NTJ4 | |
| WDQTETAPRLLRFPW | 646 | Q96L34 | |
| ALNISFQELGWERWI | 266 | P05111 | |
| ALWEITWERIDCFLP | 1696 | Q92538 | |
| PDRIAWAWKENFLEV | 421 | Q96J84 | |
| IVWDWVRQKPVLNFE | 221 | A6NGE4 | |
| IIRPSEIEKIEWDTW | 1161 | Q6ZMW3 | |
| WPEVEEALVLLQLWA | 216 | A4GXA9 | |
| IWSPVRRSDVAWNFE | 141 | P18283 | |
| FGVEWIASWLVVTVP | 221 | P09326 | |
| NWFSEWPQEALLEVA | 2916 | Q9P225 | |
| LIPIQEEEFIDWWSK | 1466 | O75923 | |
| DIPVRSFFPENWLWR | 771 | P0C0L4 | |
| NWLWRVETVDRFQIL | 781 | P0C0L4 | |
| FVYSLLWPREWLEVG | 216 | Q9UNU6 | |
| IDWFSRWPKDALVAV | 3111 | Q8TE73 | |
| AWRELFVLGIAQWAI | 221 | Q9Y466 | |
| VFPQPEAFWWRASRL | 191 | P48145 | |
| WPQFEEWSLDTQRTI | 296 | Q9UKS6 | |
| PERFSEGSIDVWWIV | 841 | Q9H2X9 | |
| FWEPDCQLIQLVWED | 331 | Q6QHF9 | |
| EKLWRNALEAWAVPV | 271 | Q11128 | |
| WLAERLGLFEELWAA | 31 | Q9BW92 | |
| FPTTELLRVWEAWRE | 281 | Q9BW92 | |
| QLTALLAWIREPWEE | 1056 | Q8N1F8 | |
| LAWIREPWEELFSIG | 1061 | Q8N1F8 | |
| PNIFWQVTWRVVSPL | 526 | Q695T7 | |
| LPQGFWAAVEVWLER | 16 | Q8IYL2 | |
| WAAVEVWLERPQVAN | 21 | Q8IYL2 | |
| NFPFWLWIESILELI | 551 | P42224 | |
| RFEAVGWWALLALVT | 51 | Q9UKY4 | |
| FDDVWRLWEVLLTGK | 251 | Q8IYX1 | |
| WRRQWVEEFFPSVSL | 576 | Q9BU23 | |
| TADQLWVPLRWIAPE | 286 | Q6ZMQ8 | |
| VTWRSADELPWLFQQ | 861 | Q7Z494 | |
| LGIFWLNAAETWVDI | 311 | Q14697 | |
| AVVDERQYIWPWLIS | 381 | Q92540 | |
| FVELFQSWQILARPW | 731 | Q96CC6 | |
| EITPDLWQEACWIVI | 16 | P30876 | |
| EWLIDVPSDLGQEWI | 106 | O95149 | |
| FLKWFVVLEETPWDA | 376 | Q9NRY4 | |
| WPDRQWGLCIFDDII | 886 | O60518 | |
| WPRWLDAELLQSFSQ | 46 | Q92935 | |
| VWNDWAIIKAALEPF | 81 | P63128 | |
| LRDPWNWLDFTVITF | 186 | P35498 | |
| PLDLRLEWVDTVWEL | 16 | P42695 | |
| AQADWAAKRLVWVPS | 26 | P35749 | |
| RDIWSWVPERFALCQ | 351 | Q9ULP9 | |
| IRNGISFTIWDRWTV | 946 | A0AVT1 | |
| FPDVLRLWEVLWTGL | 506 | Q9HA65 | |
| QVERPWLDCLWIVLA | 121 | Q5GH73 | |
| FDIRQWFLVTDWNPL | 406 | A6PVC2 | |
| IRTWSFPEEVWQVAT | 6 | A8K554 | |
| WAWLEREEFLVPKNV | 461 | Q8IU68 | |
| ARVIVIRWLVSFWLE | 301 | Q6GYQ0 | |
| GRLWVVFIVVVSVAW | 426 | P31639 | |
| RDPWNWLDFSVITLA | 186 | Q9Y5Y9 | |
| LDWLRYLVAWQPVVI | 301 | Q8N4F7 | |
| LWDVLSNEQVAWLVR | 386 | Q96MI6 | |
| FLRDPWNWLDFTVIT | 186 | Q99250 | |
| EWDPLDIAFETWEII | 731 | P24821 | |
| RRWWTLAGQEITVTF | 441 | Q9NY15 | |
| DWLRYLVAWQPVIIG | 301 | Q9H920 | |
| WKAPLNVNLIRFWVE | 1676 | P08922 | |
| QSDVWSFGILIWEIL | 2141 | P08922 | |
| AITWADRAFPSLAWI | 276 | Q8TCU3 | |
| DLRQWFLVTDWNPLT | 336 | Q9Y4R7 | |
| VLVLESWRPQALWAV | 1136 | Q9BWH6 | |
| DLDAQTWRIPRVFSW | 701 | P22102 | |
| AVWIASESWAIDPVL | 296 | Q8TE23 | |
| TKRVVYPWQLLEEIW | 411 | Q8TE23 | |
| DQWAWETLRDTVAPV | 341 | Q13464 | |
| VAIVFSQEEWQWLAP | 11 | Q96NG8 | |
| RDLQSENPEWKWFIE | 201 | A2A288 | |
| WTPRLTILEALWVDW | 116 | Q401N2 | |
| TILEALWVDWRDQSP | 121 | Q401N2 | |
| YWAAVPAVLDLWLTQ | 756 | Q9H330 | |
| RVIIWLWDILASDFT | 951 | Q7Z3V4 | |
| AAVLDQWLTLPIFAW | 111 | Q14656 | |
| FENWLIQVNEVLPDW | 61 | P0CG32 | |
| WGTLDPAQRDLFWDI | 216 | O14771 | |
| NWTERWFVLKPNIIS | 226 | Q9UH65 | |
| VATWNQILDPWVYIL | 296 | P21731 | |
| VLFTWDEWRKLAPSQ | 21 | Q96LW1 | |
| FEWNALVLVVVLGWL | 101 | P13866 | |
| IRFTWEPNFWTKQLA | 246 | O15016 | |
| QLEKAAWRWAETVRP | 6 | Q86UV5 | |
| LPQTVGDFWRLVWEQ | 896 | Q9HD43 | |
| WNLPAVTIAWLLETA | 711 | Q92547 | |
| QEEIFITDWWLSPEV | 356 | O14939 | |
| RNPSAWTVEDVVWFV | 341 | Q8N228 | |
| TQWWDAPSIVGLIIF | 316 | Q96SA4 | |
| SVACLWWDPIQRLLF | 201 | Q8IWB7 | |
| DFLDSWVHIIPVWIL | 506 | Q9UBB9 | |
| LYDAVWIQVSWLARP | 916 | P35125 | |
| RQLWDELGALWVCVV | 331 | Q9H7M6 | |
| QISWIFPDRRVWQTV | 1981 | Q9NR99 | |
| RITSVGEDWAILVWE | 646 | Q14324 | |
| PQWGLVFEKTRWIIE | 736 | Q5VVJ2 |